Nuveen Asset Management, LLC Rapt Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 77,709 shares of RAPT stock, worth $83,925. This represents 0.0% of its overall portfolio holdings.

Number of Shares

77,709

Previous 77,709 -0.0%

Holding current value

$83,925

Previous $237,000 34.18%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$2.89 - $9.38 $81,787 - $265,454	-28,300 Reduced 26.7%	77,709 $237,000
Q1 2024 May 13, 2024	BUY	$6.87 - $26.45 $16,913 - $65,119	2,462 Added 2.38%	106,009 $951,000
Q4 2023 Feb 14, 2024	BUY	$11.28 - $25.46 $70,274 - $158,615	6,230 Added 6.4%	103,547 $2.57 Million
Q3 2023 Nov 14, 2023	BUY	$16.34 - $24.66 $193,187 - $291,555	11,823 Added 13.83%	97,317 $1.62 Million
Q2 2023 Aug 14, 2023	SELL	$16.06 - $21.61 $3.87 Million - $5.2 Million	-240,680 Reduced 73.79%	85,494 $1.6 Million
Q1 2023 May 15, 2023	SELL	$17.19 - $30.8 $78,283 - $140,263	-4,554 Reduced 1.38%	326,174 $5.99 Million
Q4 2022 Feb 14, 2023	BUY	$16.28 - $24.6 $596,499 - $901,344	36,640 Added 12.46%	330,728 $6.55 Million
Q3 2022 Nov 14, 2022	BUY	$17.96 - $30.46 $3.32 Million - $5.63 Million	184,712 Added 168.88%	294,088 $7.08 Million
Q2 2022 Aug 15, 2022	SELL	$10.26 - $23.59 $368,949 - $848,296	-35,960 Reduced 24.74%	109,376 $2 Million
Q4 2021 Feb 14, 2022	SELL	$29.5 - $39.5 $460,141 - $616,121	-15,598 Reduced 9.69%	145,336 $2.7 Million
Q3 2021 Nov 12, 2021	BUY	$29.86 - $39.47 $3.19 Million - $4.22 Million	106,977 Added 198.26%	160,934 $2.99 Million
Q2 2021 Aug 16, 2021	BUY	$17.99 - $40.02 $213,469 - $474,877	11,866 Added 28.19%	53,957 $1 Million
Q1 2021 May 17, 2021	SELL	$16.0 - $24.46 $28,656 - $43,807	-1,791 Reduced 4.08%	42,091 $934,000
Q4 2020 Feb 16, 2021	BUY	$15.89 - $40.87 $7,674 - $19,740	483 Added 1.11%	43,882 $867,000
Q3 2020 Nov 16, 2020	SELL	$21.6 - $37.5 $99,295 - $172,387	-4,597 Reduced 9.58%	43,399 $1.4 Million
Q2 2020 Aug 14, 2020	BUY	$14.16 - $32.85 $679,623 - $1.58 Million	47,996 New	47,996 $1.39 Million

Others Institutions Holding RAPT

# of Institutions

104

Shares Held

27.1M

Call Options Held

26.7K

Put Options Held

2.4K

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $32M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Rapt Therapeutics, Inc. Transaction History